Casabronstein méier resultado

Kaplan-Meier analysis of clinical outcomes in critical COVID-19

Por um escritor misterioso
Last updated 14 janeiro 2025
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Frontiers Kaplan-Meier Type Survival Curves for COVID-19: A
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Viruses, Free Full-Text
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Clinical outcomes of COVID-19 in Wuhan, China: a large cohort
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Frontiers High mortality rates among COVID-19 intensive care
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Clinical and treatment factors associated with the mortality of
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Tocilizumab in Hospitalized Patients with Severe Covid-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Abnormal liver chemistries as a predictor of COVID-19 severity and
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Outpatient anti-spike monoclonal antibody administration is
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Prognostic factors associated with mortality risk and disease
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Clinical outcomes of hospitalized COVID-19 patients treated with
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Epidemiology, clinical course, and outcomes of critically ill
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19
Recomendado para você
você pode gostar

© 2014-2025 jeart-turkiye.com. All rights reserved.